ArticleEuropean urology open science2021

Real-world Evidence to Estimate Prostate Cancer Costs for First-line Treatment or Active Surveillance.

Christopher J Magnani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.